Results 61 to 70 of about 25,524 (191)

Decreased Hospital Length of Stay With Early Administration of Oseltamivir in Patients Hospitalized With Influenza

open access: yesMayo Clinic Proceedings: Innovations, Quality & Outcomes, 2020
Objective: To evaluate the effects of timely oseltamivir administration in patients hospitalized with seasonal influenza. Patients and Methods: We performed a single-center retrospective cohort study for hospitalized patients who tested positive for ...
Lin Dou, MD   +6 more
doaj   +1 more source

Renal Clearable Luminogenic Reporter for Ultrasensitive Influenza Virus Imaging and Efficient Antiviral Therapies Monitoring in Living Mice

open access: yesAdvanced Science, Volume 13, Issue 57, 14 October 2026.
A viral luminogenic reporter with chemiluminescence/fluorescence dual‐response and efficient renal clearance was developed for non‐invasive imaging and urinalysis of H1N1 virus protease, allowing for remote detection of H1N1 virus infections and monitoring of antiviral therapeutic efficacy in living mice.
Bankang Ruan   +9 more
wiley   +1 more source

One-way sensitivity analyses tornado diagram: Empiric treatment with oseltamivir vs. post RIDT treatment with oseltamivir.

open access: yes, 2016
One-way sensitivity analyses tornado diagram: Empiric treatment with oseltamivir vs. post RIDT treatment with oseltamivir.
Jiuhong Wu (2615215)   +3 more
core   +1 more source

From Exposure to Guided Participation: Designing Experiential Education as Cognitive Apprenticeships

open access: yesJACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 10, October 2026.
ABSTRACT Experiential pharmacy education is expected to develop trainees who can participate in patient care, reason through ambiguity, communicate with interprofessional teams, and progress toward practice‐ready or independent performance. Pharmacy practice experiences are often organized around clinical exposure, topic discussions, patient ...
W. Anthony Hawkins   +2 more
wiley   +1 more source

Improvement of influenza-related symptoms in the azithromycin-oseltamivir combination therapy and oseltamivir monotherapy groups.

open access: yes, 2014
Improvement of influenza-related symptoms in the azithromycin-oseltamivir combination therapy and oseltamivir monotherapy groups.
Masafumi Seki (535641)   +12 more
core   +1 more source

Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support. [PDF]

open access: yesPLoS ONE, 2010
INTRODUCTION: To evaluate the effect of extracorporeal membrane oxygenation (ECMO) support on pharmacokinetics of oseltamivir and oseltamivir carboxylate (OC) in children.
Enno D Wildschut   +5 more
doaj   +1 more source

Progressive emergence of an oseltamivir-resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient [PDF]

open access: yes, 2013
A minor viral population of oseltamivir-resistant A(H3N2) viruses (E119V neuraminidase mutation) was selected and maintained in a continually infected immunocompromised child following initial oseltamivir treatment.
Tiedemann, K   +7 more
core   +1 more source

Typical RMSDs of oseltamivir in the trajectories produced binding events.

open access: yes, 2022
The RMSD of heavy atoms of oseltamivir was calculated by referring those of oseltamivir of the crystal structure.
Jiajing Ouyang (13171048)   +18 more
core   +1 more source

Dual Antiviral and Immunomodulatory Effects of Phytochemicals in Influenza A Virus Infection: Targeting Key Host Signaling Pathways

open access: yesMicrobiologyOpen, Volume 15, Issue 5, October 2026.
Influenza A virus modulates host innate immune pathways, including TLR, RIG‐I, MAPK, and NF‐κB signaling, to support replication and drive inflammatory pathology. Plant‐derived phytocompounds target these interconnected pathways, offering a potential host‐directed immunomodulatory approach complementary to conventional antivirals.
Dibakar Chowdhury   +3 more
wiley   +1 more source

Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.

open access: yesPLoS ONE, 2019
BACKGROUND:Neuraminidase inhibitors (NAIs) effectively treat influenza. The clinical effectiveness of four NAIs (oseltamivir, zanamivir, laninamivir, and peramivir) was evaluated against influenza A/H1N1pdm09, A/H3N2, and B viruses.
Momoko Mawatari   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy